• SCL Lifesciences Ltd, a pharmaceutical manufacturer based in Hyderabad, is seeking its first round of external funding. The company is considering selling a majority stake in the business.
• The potential valuation for SCL Lifesciences is estimated to be between Rs 1,500 crore and Rs 1,800 crore (approximately $168 million to $202 million). Global investment bank BDA Partners is assisting in finding potential buyers.
• Established in 1993, SCL Lifesciences serves both domestic and international markets, with 80% of its revenue generated from overseas clients. The company operates two manufacturing facilities in Chandigarh and a knowledge center in Hyderabad, employing 900 professionals.
• Despite a slight decrease in net sales to Rs 325 crore in FY25 from Rs 341 crore in the previous year, SCL Lifesciences saw an increase in profit after tax to Rs 58 crore from Rs 53.5 crore. This funding round occurs amidst continued investor interest in India's pharmaceutical sector.

Debjyoti Roy

Hyderabad-based pharmaceutical manufacturer SCL Lifesciences Ltd (formerly Saurav Chemicals) is eyeing its maiden .........

API maker SCL Lifesciences eyes maiden PE cheque, hires banker

Private Equity

Healthcare

Pharmaceuticals

Hyderabad-based pharmaceutical manufacturer&nbsp;SCL Lifesciences Ltd (formerly Saurav Chemicals) is eyeing its maiden round of external funding, at least...

Saurav Chemicals

SCL Lifesciences

JB Chemicals and Pharmaceuticals

Nosch Labs

Matrix Pharmacorp Pvt Ltd

VC_Desk_Story_Masthead

VC_Desk_Story_A_300x250

VC_Desk_Story_B_300x250

VC_Desk_Story_C_300x250

VC_Desk_Story_D_300x250

VC_Desk_Story_E_300x250

VC_Desk_Story_A_Skyscraper

VC_Desk_Story_B_Skyscraper

VC_Desk_Story_Inline_A_300x250

VC_Desk_Story_Inline_B_300x250

VC_Desk_Story_Inline_C_300x250

VC_Desk_Story_Inline_D_300x250

VC_Desk_Story_Inline_E_300x250

VC_Desk_Story_Footer

Corona Remedies Ltd made a spectacular stock market debut on Monday with shares of the drugmaker that counts private ......

ChrysCap-backed Corona Remedies nears $1 bn valuation after blockbuster debut

Bengaluru-based NU Hospitals Pvt Ltd is in the final stages of closing a funding round that has been in the ......

NU Hospitals in final lap of closing funding round

Baby Memorial Hospital, a multispecialty hospital backed by private equity major KKR & Co, is set to acquire a south ......

KKR set to acquire another South India hospital operator

Fireside Ventures-backed at-home diagnostics firm Inito has raised fresh capital to expand its offerings beyond ......

Fireside Ventures-backed healthtech firm Inito bags $29 mn in Series B

Private equity firm Vixar, which was earlier known as Arpwood Partners and rebranded this year, has acquired a majority ......

PE firm Vixar picks up majority stake in diagnostics firm

Consumer

Infrastructure

Private equity firm KKR, Singapore state investment firm Temasek, venture capital firm Aarin Capital and two other PE ......

KKR, Temasek, three other PE/VC firms move closer to harvesting India bets

Medway Hospitals, a South India-based chain of multi-speciality hospitals, is considering its maiden institutional ......

API maker SCL Lifesciences eyes maiden PE cheque, hires banker

This is a Premium article. Please subscribe or log in to read the full story!

Related Articles

Healthcare

ChrysCap-backed Corona Remedies nears $1 bn valuation after blockbuster debut

Healthcare

NU Hospitals in final lap of closing funding round

Healthcare

KKR set to acquire another South India hospital operator

Healthcare

Fireside Ventures-backed healthtech firm Inito bags $29 mn in Series B

Healthcare

PE firm Vixar picks up majority stake in diagnostics firm

Consumer

KKR, Temasek, three other PE/VC firms move closer to harvesting India bets

Healthcare

South India-based Medway Hospitals plans first PE round, hires banker

Google News